Drug intelligence / Profile preview

PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)

Development stage: Unknown
Modality: Small Molecules
Administration: Oral, Intravenous, Subcutaneous, Rectal

Overview

PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE) is a synthetic organic compound belonging to the class of pyrimidine dicarboxamides. It features a pyrimidine core with two carboxamide groups at positions 4 and 6, each linked to a 3-methyl-benzylamine moiety. While structurally related compounds have been identified as pharmaceuticals or drug candidates in chemical databases, specific information regarding the development, mechanism of action, or therapeutic indications for this exact compound is not publicly available.

Beyond the preview

Go deeper on PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE).

Explore the full profile